Learn more about how NCATS will bridge translational science gaps to address the opioid crisis in the July 2018 NCATS Director's Message.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- About NCATS
- Center Overview
- Director's Corner
- 2013 Director's Messages
2013 Director's Messages Director's Messages
We all are aware that chemicals can be helpful or harmful to our health, but the systems we have for evaluating those effects are, like so many aspects of translational research, inefficient and often ineffective. Chemicals can be more than just life-saving (e.g., penicillin) or life-ending (e.g., cyanide)...
In recent years, basic scientists have made breathtaking advances in our understanding of the human body’s biology and chemistry. The human genome has been sequenced, stem cells understood and RNA interference discovered. All of these advances have been celebrated for holding enormous promise for improving human health...
In an increasingly multidisciplinary research world, innovative scientific advances require effective collaborations. As I often say, translation is a team sport. These partnerships — among academia, government, industry and nonprofits — enable and speed the development of promising interventions to prevent and treat disease...
A major NCATS mission is to develop new technologies and models that scientists in many different fields can use to advance translational research and ultimately improve health. Given the enormous opportunities and needs in translational science, we are particularly interested in “game-changing” technologies that could revolutionize the field...
Much has been written about scientific and operational problems that limit our ability to develop and deploy new and effective interventions to improve human health. Much less has been written about potential solutions to these problems — and that’s where NCATS comes in. We focus on developing these kinds of system-wide solutions...
My previous Director’s Messages have emphasized that translation is a team sport, describing my ongoing discussions with leaders from academia, government, industry and patient advocacy groups. The feedback from these conversations helps NCATS focus its priorities on the areas of greatest need and build the teams necessary to solve complex translational science problems that can prevent and delay the development of health-improving interventions...
In the five months since I took over as NCATS director, I have visited with a wide variety of constituents who have a stake in what we do — patients, grantees, companies, and scientists and physicians across NIH and elsewhere — and it has become clear to me that many, perhaps most, do not fully understand what “translational science” is. This knowledge gap leads to mystification at best, and misconception at worst, about what NCATS is doing and will do...
Send FeedbackNCATS Director on NIH HEAL InitiativeTranslating Translation
Former NCATS Director Christopher P. Austin, M.D., defines, distinguishes and explores the promise of translation, translational research and translational science.
- Funding & Notices
-